Novo Nordisk and Eli Lilly said they've agreed to sell their blockbuster drugs Wegovy and Zepbound at a discount.
Even after Trump’s new deal, obesity drugs are still too expensive.
President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce p ...
President Trump appeared in the oval office with executives from the companies behind GLP1 weight loss drug Wegovy and ...
RFK Jr. has railed against drugmakers but he struck a different tone in commenting on President Trump's deal to expand access to obesity drugs ...
(Reuters) -The U.S. Food and Drug Administration said on Thursday it has awarded six more companies, including Eli Lilly and ...
President Donald Trump promises lower prices for weight loss drugs and reveals, one of his key staff members has a ...
“The lowest price, of $150 a month, will be available only for the lowest doses of the pill form of the drugs. When those drugs reach the market, Medicare and Medicaid will pay that price, as will ...
Medicare beneficiaries will soon be able to get obesity and Type 2 diabetes drugs for a $50 copay. But there are some ...
President Trump announced a deal with Eli Lilly and Novo Nordisk to lower prices on hugely popular weight-loss drugs for Medicare, Medicaid and American patients who pay with their own money.
President Donald Trump has unveiled a deal with drugmakers Eli Lilly and Novo Nordisk to reduce prices for their obesity ...
The Trump administration announced deals on Thursday with pharmaceutical giants Novo Nordisk and Eli Lilly that would lower the cost of GLP-1 drugs for many Americans.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results